MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1111/liv.70314

Медицинская библиотека · Liver international : official journal of the International Association for the Study of the Liver · 2025

Smoking Aggravates Inflammation, Fibrogenesis, Angiogenesis and Cancer Risk in Patients With Cirrhosis.

Dominik Nina, Simbrunner Benedikt, Scheiner Bernhard, Schwarz Michael, Hartl Lukas, Jachs Mathias, Balcar Lorenz, Semmler Georg, Kramer Georg, Sebesta Christian, Trauner Michael, Pinter Matthias, Mandorfer Mattias, Reiberger Thomas, Hofer Benedikt Silvester

СтатьяНаблюдательное исследованиеПоддержка исследования: вне правительства СШАПеревод в очереди

Аннотация

BACKGROUND AND AIMS: Smoking induces a proinflammatory state, yet its role in advanced chronic liver disease (ACLD) remains understudied. This study evaluated its impact on disease-driving mechanisms and clinical outcomes in ACLD patients.

METHODS

ACLD patients undergoing hepatic venous pressure gradient measurements from 2017 to 2021 were included. The association of smoking with biomarkers of inflammation, fibrogenesis, angiogenesis and the incidence of hepatocellular carcinoma (HCC), extrahepatic malignancies and mortality was examined.

RESULTS

Among 339 ACLD patients (66.1% men, median age: 56.8 years, MELD: 11, HVPG: 17 mmHg), 62% (n = 210) were ever-smokers (n = 78 former, n = 132 active). Compared to never/former smokers, active smokers exhibited significantly higher white blood cell counts (5.49 vs. former: 4.74 vs. never: 4.25 G/L; p < 0.001) and C-reactive protein levels (CRP: 0.36 vs. former: 0.29 vs. 0.21 mg/dL; p = 0.035). Active smokers showed upregulated fibrogenic (TIMP-1: 364 vs. former: 324 vs. never: 278 ng/mL, p < 0.001; P3NP: 20.9 vs. former: 15.6 vs. never: 17.2 μg/L, p = 0.008) and angiogenic (PLGF: 21.7 vs. former: 18.2 vs. never: 19.0 pg/mL, p = 0.004) activity markers. Over a median follow-up of 30.4 months, ever-smokers exhibited a higher incidence of extrahepatic malignancies (SHR: 11.30; p = 0.019) and numerically higher HCC incidence (SHR: 2.27 p = 0.150; mostly evident in Child-Pugh A patients: SHR: 7.44, p = 0.053). All-cause or liver-related mortality risk did not differ significantly between ever-smokers and never-smokers.

CONCLUSION

Smoking is linked to an upregulation of inflammatory, fibrogenic and angiogenic processes in ACLD and increases the risk of extrahepatic malignancies. These findings underscore the importance of strategies supporting smoking cessation in ACLD patients.

TRIAL REGISTRATION: NCT03267615.

Для цитирования: Dominik Nina, Simbrunner Benedikt, Scheiner Bernhard, Schwarz Michael, Hartl Lukas, Jachs Mathias, Balcar Lorenz, Semmler Georg, Kramer Georg, Sebesta Christian, Trauner Michael, Pinter Matthias, Mandorfer Mattias, Reiberger Thomas, Hofer Benedikt Silvester. Smoking Aggravates Inflammation, Fibrogenesis, Angiogenesis and Cancer Risk in Patients With Cirrhosis.. Liver international : official journal of the International Association for the Study of the Liver. 2025. DOI: 10.1111/liv.70314.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.